NIM
NEOS Investment Management Portfolio holdings
AUM
$8.08B
This Quarter Return
+4.83%
1 Year Return
+24.46%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$4.25B
AUM Growth
+$4.25B
(+28%)
Cap. Flow
+$886M
Cap. Flow
% of AUM
20.88%
Top 10 Holdings %
Top 10 Hldgs %
37.69%
Holding
613
New
34
Increased
490
Reduced
55
Closed
25
Top Buys
| 1 |
Vanguard Russell 2000 ETF
VTWO
|
$76.3M |
| 2 |
Apple
AAPL
|
$70.6M |
| 3 |
NVIDIA
NVDA
|
$54.5M |
| 4 |
Microsoft
MSFT
|
$53.4M |
| 5 |
Amazon
AMZN
|
$39.8M |
Top Sells
| 1 |
SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
|
$17.1M |
| 2 |
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
|
$17.1M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
$3.06M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$2.53M |
| 5 |
Insulet
PODD
|
$1.32M |
Sector Composition
| 1 | Technology | 33.68% |
| 2 | Consumer Discretionary | 10.52% |
| 3 | Healthcare | 10.01% |
| 4 | Communication Services | 9.79% |
| 5 | Financials | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
BridgeBio Pharma
BBIO
$9.89B
| $3.9M | 0.09% |
141,972
+29,896
| +27% | +$820K |
|
202
Becton Dickinson
BDX
$55.3B
| $3.84M | 0.09% |
16,939
+4,136
| +32% | +$938K |
|
203
Alnylam Pharmaceuticals
ALNY
$58.5B
| $3.84M | 0.09% |
16,323
-1,853
| -10% | -$436K |
|
204
Apollo Global Management
APO
$77.9B
| $3.82M | 0.09% |
+23,159
| New | +$3.82M |
|
205
Capital One
COF
$145B
| $3.79M | 0.09% |
21,265
+4,974
| +31% | +$887K |
|
206
Trade Desk
TTD
$26.7B
| $3.7M | 0.09% |
31,486
+5,259
| +20% | +$618K |
|
207
Johnson Controls International
JCI
$69.9B
| $3.7M | 0.09% |
46,853
+15,356
| +49% | +$1.21M |
|
208
Allegion
ALLE
$14.6B
| $3.66M | 0.09% |
28,014
+5,030
| +22% | +$657K |
|
209
Axon Enterprise
AXON
$58.7B
| $3.64M | 0.09% |
6,125
+5,143
| +524% | +$3.06M |
|
210
Oneok
OKE
$48.1B
| $3.61M | 0.09% |
35,995
+8,609
| +31% | +$864K |
|
211
Bank of New York Mellon
BK
$74.5B
| $3.58M | 0.08% |
46,647
+11,200
| +32% | +$860K |
|
212
ASML
ASML
$292B
| $3.58M | 0.08% |
5,162
+592
| +13% | +$410K |
|
213
Truist Financial
TFC
$60.4B
| $3.57M | 0.08% |
82,371
+19,811
| +32% | +$859K |
|
214
Target
TGT
$43.6B
| $3.57M | 0.08% |
26,410
+6,219
| +31% | +$841K |
|
215
Strategy Inc Common Stock Class A
MSTR
$94.8B
| $3.54M | 0.08% |
+12,224
| New | +$3.54M |
|
216
CoStar Group
CSGP
$37.9B
| $3.54M | 0.08% |
49,379
+9,553
| +24% | +$684K |
|
|
ANSS
217
DELISTED
Ansys
ANSS
| $3.53M | 0.08% |
10,451
+1,833
| +21% | +$618K |
|
218
Carrier Global
CARR
$55.5B
| $3.51M | 0.08% |
51,487
+12,343
| +32% | +$843K |
|
219
ON Semiconductor
ON
$20.3B
| $3.51M | 0.08% |
55,677
+11,120
| +25% | +$701K |
|
220
CVS Health
CVS
$92.8B
| $3.49M | 0.08% |
77,773
+18,667
| +32% | +$838K |
|
221
Schlumberger
SLB
$55B
| $3.36M | 0.08% |
87,694
+21,054
| +32% | +$807K |
|
222
Freeport-McMoran
FCX
$63.7B
| $3.34M | 0.08% |
87,735
+21,054
| +32% | +$802K |
|
223
Warner Bros
WBD
$28.8B
| $3.25M | 0.08% |
307,864
+62,112
| +25% | +$657K |
|
224
Kinder Morgan
KMI
$60B
| $3.25M | 0.08% |
118,720
+28,522
| +32% | +$782K |
|
225
Aflac
AFL
$57.2B
| $3.24M | 0.08% |
31,360
+7,465
| +31% | +$772K |
|